- within Food, Drugs, Healthcare and Life Sciences topic(s)
- in United Kingdom
- with readers working within the Advertising & Public Relations and Law Firm industries
- within Food, Drugs, Healthcare, Life Sciences, Strategy and Technology topic(s)
Our research finds that Life Sciences CEOs are confident in industry growth fueled by innovation, technological advancement, and operational efficiency. There is a strong appetite for mergers and acquisitions, substantial investments in AI and digitalisation, and a critical need to empower the workforce to navigate rapid change. While sustainability and ESG remain high on the agenda for Life Sciences organisations globally, there are shifting priorities across regions.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.